Lyell Immunopharma
LYEL
LYEL
68 hedge funds and large institutions have $371M invested in Lyell Immunopharma in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.34% more ownership
Funds ownership: 53.55% → 56.88% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
97% less call options, than puts
Call options by funds: $34K | Put options by funds: $1.15M
Holders
68
Holding in Top 10
9
Calls
$34K
Puts
$1.15M
Top Buyers
| 1 | +$3.02M | |
| 2 | +$2.21M | |
| 3 | +$2.16M | |
| 4 |
DC
Decheng Capital
Menlo Park,
California
|
+$2.16M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.64M |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$1.49M | |
| 3 | -$840K | |
| 4 |
Renaissance Technologies
New York
|
-$548K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$471K |
